In Reply
- PMID: 33759747
- PMCID: PMC8182780
- DOI: 10.3238/arztebl.m2021.0043
In Reply
Comment on
-
The Neurofibromatoses.Dtsch Arztebl Int. 2020 May 15;117(20):354-360. doi: 10.3238/arztebl.2020.0354. Dtsch Arztebl Int. 2020. PMID: 32657748 Free PMC article. Review.
-
Screening: The Significance of Pheochromocytoma.Dtsch Arztebl Int. 2021 Jan 29;118(4):56. doi: 10.3238/arztebl.m2021.0042. Dtsch Arztebl Int. 2021. PMID: 33759746 Free PMC article. No abstract available.
References
-
- Gruber LM, Erickson D, Babovic-Vuksanovic D, Thompson GB, Young Jr. WF, Bancos I. Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1. Clin Endocrinol (Oxf) 2017;86:141–149. - PubMed
-
- Ayala-Ramirez M, Feng L, Johnson MM, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011;96:717–725. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
